Ubs Group Ag Tekla Life Sciences Investors Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Ubs Group Ag holds 42,084 shares of HQL stock, worth $673,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,084

Previous 37,409 12.5%

Holding current value

$673,344

Previous $474,000 13.71%

% of portfolio

0.0%

Previous 0.0%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$10.87 - $13.02 $50,817 - $60,868	4,675 Added 12.5%	42,084 $539,000
Q1 2025 May 13, 2025	SELL	$12.69 - $14.36 $390,280 - $441,641	-30,755 Reduced 45.12%	37,409 $474,000
Q4 2024 Feb 14, 2025	BUY	$13.12 - $15.25 $234,559 - $272,639	17,878 Added 35.55%	68,164 $894,000
Q3 2024 Nov 14, 2024	SELL	$14.26 - $15.78 $96,540 - $106,830	-6,770 Reduced 11.87%	50,286 $758,000
Q2 2024 Aug 13, 2024	BUY	$12.79 - $14.27 $188,639 - $210,468	14,749 Added 34.86%	57,056 $808,000
Q1 2024 May 13, 2024	BUY	$13.38 - $14.33 $71,756 - $76,851	5,363 Added 14.52%	42,307 $576,000
Q4 2023 Feb 09, 2024	SELL	$11.35 - $13.6 $79,007 - $94,669	-6,961 Reduced 15.85%	36,944 $497,000
Q3 2023 Nov 09, 2023	SELL	$12.38 - $13.69 $52,837 - $58,428	-4,268 Reduced 8.86%	43,905 $547,000
Q2 2023 Aug 11, 2023	BUY	$13.13 - $14.17 $27,796 - $29,997	2,117 Added 4.6%	48,173 $652,000
Q1 2023 May 12, 2023	SELL	$13.37 - $14.94 $83,041 - $92,792	-6,211 Reduced 11.88%	46,056 $641,000
Q4 2022 Feb 08, 2023	SELL	$13.55 - $15.23 $158,480 - $178,130	-11,696 Reduced 18.29%	52,267 $742,000
Q3 2022 Nov 10, 2022	SELL	$13.39 - $16.31 $245,037 - $298,473	-18,300 Reduced 22.25%	63,963 $874,000
Q2 2022 Aug 10, 2022	SELL	$13.11 - $17.02 $354,350 - $460,033	-27,029 Reduced 24.73%	82,263 $1.17 Million
Q1 2022 May 16, 2022	SELL	$15.35 - $19.29 $192,243 - $241,587	-12,524 Reduced 10.28%	109,292 $1.81 Million
Q4 2021 Feb 14, 2022	BUY	$18.5 - $21.59 $75,720 - $88,367	4,093 Added 3.48%	121,816 $2.34 Million
Q3 2021 Nov 15, 2021	BUY	$20.27 - $22.67 $60,262 - $67,397	2,973 Added 2.59%	117,723 $2.45 Million
Q2 2021 Aug 13, 2021	SELL	$19.14 - $21.44 $130,496 - $146,177	-6,818 Reduced 5.61%	114,750 $2.46 Million
Q1 2021 May 12, 2021	BUY	$19.31 - $22.07 $324,099 - $370,422	16,784 Added 16.02%	121,568 $2.4 Million
Q4 2020 Feb 11, 2021	BUY	$16.8 - $20.21 $90,955 - $109,416	5,414 Added 5.45%	104,784 $2.07 Million
Q3 2020 Nov 12, 2020	BUY	$16.71 - $19.06 $108,882 - $124,194	6,516 Added 7.02%	99,370 $1.75 Million
Q2 2020 Jul 31, 2020	BUY	$14.22 - $18.38 $857,935 - $1.11 Million	60,333 Added 185.52%	92,854 $1.67 Million
Q1 2020 May 01, 2020	SELL	$12.22 - $17.99 $19,075 - $28,082	-1,561 Reduced 4.58%	32,521 $487,000
Q4 2019 Feb 14, 2020	BUY	$14.63 - $17.84 $182,245 - $222,232	12,457 Added 57.6%	34,082 $594,000
Q3 2019 Nov 14, 2019	SELL	$15.09 - $17.09 $10,004 - $11,330	-663 Reduced 2.97%	21,625 $326,000
Q2 2019 Aug 14, 2019	SELL	$15.54 - $17.47 $26,651 - $29,961	-1,715 Reduced 7.14%	22,288 $375,000
Q1 2019 May 14, 2019	BUY	$15.5 - $17.9 $47,662 - $55,042	3,075 Added 14.69%	24,003 $411,000
Q4 2018 Feb 14, 2019	SELL	$13.99 - $20.35 $26,818 - $39,010	-1,917 Reduced 8.39%	20,928 $316,000
Q3 2018 Nov 14, 2018	SELL	$18.89 - $20.49 $344,175 - $373,327	-18,220 Reduced 44.37%	22,845 $466,000
Q2 2018 Aug 14, 2018	SELL	$18.13 - $19.4 $101,165 - $108,251	-5,580 Reduced 11.96%	41,065 $772,000
Q1 2018 May 15, 2018	BUY	$18.92 - $21.52 $48,813 - $55,521	2,580 Added 5.85%	46,645 $896,000
Q4 2017 Feb 14, 2018	SELL	$18.31 - $22.24 $434,477 - $527,732	-23,729 Reduced 35.0%	44,065 $865,000
Q3 2017 Nov 14, 2017	BUY	$20.12 - $21.88 $262,002 - $284,921	13,022 Added 23.77%	67,794 $1.46 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-8,072 Reduced 12.84%	54,772 $1.14 Million
Q1 2017 Nov 14, 2017	BUY	N/A	62,844	62,844 $1.22 Million

Others Institutions Holding HQL

# of Institutions

Shares Held

9.41M

Call Options Held

Put Options Held

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account